Todd Harris, President and CEO at Tyra Biosciences, Inc. (TYRA), sold 500 shares at $24.00 ($12K) on 2024-09-30, disclosed to the SEC on 2024-10-02.
Scheduled sale ($12k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |
| TYRA | SELL | 2024-02-06 | $3.3M | — | Filing → |